top of page

Navigating The Fragmented World of Public ScRNA Data: 
5 Strategies for Building An 
AI-Ready Data Corpus

INFOGRAPHIC

We’re living in the era of big data and AI/ML. Public scRNA-seq data - with thousands of datasets and hundreds of millions of cells - can form a valuable data corpus for building more robust, data-driven models to uncover cellular heterogeneity, accelerate target and biomarker discovery.

 

But turning this massive, fragmented resource into something truly useful requires more than just access - it takes careful curation, standardization, and thoughtful analysis.

 

This infographic walks through a set of practical strategies to help you get there, summarized from our years of curating scRNA-seq data. From selecting the right datasets and building consistent processing workflows, to harmonizing metadata and ensuring reproducibility, it highlights what actually matters when working with public scRNA-seq data at scale. Whether you're integrating datasets or preparing data for downstream applications like biomarker discovery or AI/ML, these best practices will help you extract more reliable and meaningful insights.

​

​

What you'll learn: 

  • Key challenges in curating and building an AI/ML-ready single-cell database / data corpus 

  • 5 strategies to navigate the complexity of public scRNA-seq data 

  • How we build our Pythiomics single-cell database 

​

Request to download the infographic

Infographic - 5 strategies for building an AI ready single cell data corpus.png (2).png

Explore Pythiomics:
A multi-omics database centered on quality, structure, and tracebility.

Pythiomics is a multi-omics database developed and curated by Pythia Biosciences with an aim to create a single, united multi-omics database for scientists to explore. By combining state-of-the-art AI techniques for metadata harmonization and cell type prediction with meticulous manual curation and quality control, Pythiomics DB provides a standardized and reliable data resource for biopharmaceutical companies and research institutions to accelerate data analysis, data integration, and data-driven drug discovery.

bottom of page